Patients treated with a tumor necrosis factor-a inhibitor are more likely to develop extrapulmonary tuberculosis.

The Korean journal of internal medicine

PubMedID: 23526871

Lee SO. Patients treated with a tumor necrosis factor-a inhibitor are more likely to develop extrapulmonary tuberculosis. Korean J Intern Med. 2013;28(2):159-61.
An abstract is not available. Please access the article through the links below.